Hyderabad, Oct. 23 (UNI): In a major breakthrough for global child health, Hyderabad-based Vaccine M

Hyderabad, Oct. 23 (UNI): In a major breakthrough for global child health, Hyderabad-based Vaccine Maker Bharat Biotech International Limited (BBIL) has finalised an equitable pricing agreement with UNICEF and Gavi, the Vaccine Alliance, to reduce the cost of the RTS,S/AS01 malaria vaccine by roughly 40 percent, down to €5.50 per dose. The procurement deal, backed by upfront capital from the International Finance Facility for Immunisation (IFFIm), is scheduled to take effect in early 2027, the Bharat Biotech said in a release on Friday. It will unlock approximately $50 million in savings for national immunization budgets through 2029-funding enough supply to…